BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15624894)

  • 1. Voriconazole-induced musical hallucinations.
    Agrawal AK; Sherman LK
    Infection; 2004 Oct; 32(5):293-5. PubMed ID: 15624894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
    J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole-associated visual disturbances and hallucinations.
    Bayhan GI; Garipardic M; Karaman K; Akbayram S
    Cutan Ocul Toxicol; 2016 Mar; 35(1):80-2. PubMed ID: 25799212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complex visual hallucinations induced by voriconazole].
    Fernández-Ruiz M; López-Medrano F; Gutiérrez E; Aguado JM
    Med Clin (Barc); 2009 Jun; 133(4):156-7. PubMed ID: 19540418
    [No Abstract]   [Full Text] [Related]  

  • 5. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hallucinosis as side effect of voriconazole].
    Flox Benítez G; Rondón Fernández P; Quero Escalada M; Fernández Ballesteros A
    Rev Clin Esp; 2005 Dec; 205(12):632-3. PubMed ID: 16527191
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to voriconazole.
    Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
    Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole : a review of its use in the management of invasive fungal infections.
    Scott LJ; Simpson D
    Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallucinations during voriconazole therapy.
    Zonios DI; Gea-Banacloche J; Childs R; Bennett JE
    Clin Infect Dis; 2008 Jul; 47(1):e7-e10. PubMed ID: 18491963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Voriconazole safety: short review of clinical data].
    Veselov AV; Belousov DIu
    Antibiot Khimioter; 2006; 51(3-4):19-25. PubMed ID: 17165257
    [No Abstract]   [Full Text] [Related]  

  • 11. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
    Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug events complicate antifungal therapy for pulmonary aspergilloma.
    Pakyz A; Bearman G
    Consult Pharm; 2008 Oct; 23(10):804-8. PubMed ID: 19032016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    Gendrot A; de La Blanchardière A; de La Gastine B; Fromager G; Massias L; Verdon R
    Rev Med Interne; 2010 Feb; 31(2):163-6. PubMed ID: 19457596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole. UK 109496.
    Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
    [No Abstract]   [Full Text] [Related]  

  • 16. Voriconazole versus amphotericin B in cancer patients with neutropenia.
    Jørgensen KJ; Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
    Mattiuzzi GN; Cortes J; Alvarado G; Verstovsek S; Koller C; Pierce S; Blamble D; Faderl S; Xiao L; Hernandez M; Kantarjian H
    Support Care Cancer; 2011 Jan; 19(1):19-26. PubMed ID: 19956980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
    Pea F; Viale P
    Ther Drug Monit; 2009 Feb; 31(1):135-6. PubMed ID: 19077926
    [No Abstract]   [Full Text] [Related]  

  • 19. Voriconazole in the treatment of invasive fungal infections.
    Keady S; Thacker M
    Intensive Crit Care Nurs; 2005 Dec; 21(6):370-3. PubMed ID: 15985371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole: a new triazole antifungal agent.
    Johnson LB; Kauffman CA
    Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.